- Home
- BRKR vs CORT Comparison
BRKR vs CORT Comparison
Compare BRKR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRKR | CORT |
|---|---|---|
| Founded | 1960 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 7.6B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRKR | CORT |
|---|---|---|
| Price | $45.46 | $88.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | $46.45 | ★ $139.00 |
| AVG Volume (30 Days) | ★ 2.4M | 690.9K |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | ★ $3,438,900,000.00 | $741,172,000.00 |
| Revenue This Year | $3.61 | $23.79 |
| Revenue Next Year | $1.23 | $40.97 |
| P/E Ratio | ★ N/A | $100.74 |
| Revenue Growth | 6.10 | ★ 17.92 |
| 52 Week Low | $28.53 | $49.00 |
| 52 Week High | $64.64 | $117.33 |
Technical Indicators
Market Signals| Indicator | BRKR | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 69.18 |
| Support Level | $44.96 | $81.31 |
| Resistance Level | $47.90 | $87.19 |
| Average True Range (ATR) | 1.85 | 2.87 |
| MACD | -0.57 | 0.73 |
| Stochastic Oscillator | 17.86 | 94.85 |
Price Performance
Historical ComparisonAbout BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.